Intellia Therapeutics Gets New Chief Post author:Sam Post published:December 17, 2017 Post category:BioPharma Intellia has named John Leonard, M.D., President and CEO, effective January 1, 2018. Source: BioSpace You Might Also Like Isogenica Limited Introduces Next-Generation, Fully Synthetic Human Fab Antibody Fragment Library May 2, 2017 Egalet Reports First Quarter 2017 Financial Results May 9, 2017 Teewinot Life Sciences Announces Breakthrough Commercial Production Of The Cannabinoid Varin Series February 13, 2017
Isogenica Limited Introduces Next-Generation, Fully Synthetic Human Fab Antibody Fragment Library May 2, 2017
Teewinot Life Sciences Announces Breakthrough Commercial Production Of The Cannabinoid Varin Series February 13, 2017
